1.34
                                            
            Talphera Inc stock is traded at $1.34, with a volume of 191.18K.
            It is up +8.06% in the last 24 hours and up +50.02% over the past month.
            Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
        
        See More
    Previous Close:
              $1.24
            Open:
              $1.23
            24h Volume:
                191.18K
            Relative Volume:
              0.08
            Market Cap:
                $27.50M
            Revenue:
              $2.82M
            Net Income/Loss:
              $-14.20M
            P/E Ratio:
              -1.5765
            EPS:
                -0.85
            Net Cash Flow:
                $-15.13M
            1W Performance:
              +16.52%
            1M Performance:
              +50.02%
            6M Performance:
                +173.47%
            1Y Performance:
              +42.77%
            Talphera Inc Stock (TLPH) Company Profile
Compare TLPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                TLPH
                            
                             Talphera Inc | 1.34 | 59.91M | 2.82M | -14.20M | -15.13M | -0.85 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy | 
| Jul-20-20 | Downgrade | Credit Suisse | Neutral → Underperform | 
| Nov-11-19 | Downgrade | Credit Suisse | Outperform → Neutral | 
| Aug-05-19 | Resumed | Credit Suisse | Outperform | 
| Jul-10-19 | Resumed | Credit Suisse | Outperform | 
| Apr-24-19 | Resumed | B. Riley FBR | Buy | 
| Feb-15-19 | Initiated | Credit Suisse | Outperform | 
| Oct-23-18 | Initiated | B. Riley FBR | Buy | 
| Oct-13-17 | Downgrade | Jefferies | Buy → Hold | 
| Oct-13-17 | Reiterated | RBC Capital Mkts | Outperform | 
| Jul-14-17 | Resumed | Jefferies | Buy | 
| Sep-15-16 | Reiterated | ROTH Capital | Buy | 
| Aug-05-16 | Downgrade | Stifel | Buy → Hold | 
| Oct-30-15 | Upgrade | Jefferies | Hold → Buy | 
| Oct-05-15 | Reiterated | ROTH Capital | Buy | 
| Sep-02-15 | Initiated | H.C. Wainwright | Buy | 
| Jul-10-15 | Resumed | ROTH Capital | Buy | 
| May-06-15 | Reiterated | Mizuho | Neutral | 
| May-05-15 | Reiterated | RBC Capital Mkts | Outperform | 
| Mar-10-15 | Reiterated | RBC Capital Mkts | Outperform | 
| Mar-09-15 | Downgrade | Mizuho | Buy → Neutral | 
                    View All
                     
                  
                Talphera Inc Stock (TLPH) Latest News
Is Talphera Inc. stock trading near support levelsWeekly Gains Summary & AI Optimized Trade Strategies - newser.com
Is Talphera Inc. showing signs of accumulationMarket Performance Report & Long-Term Capital Growth Ideas - newser.com
Why Talphera Inc. (R5XA) stock is favored by hedge funds2025 Fundamental Recap & Capital Protection Trading Alerts - newser.com
Regression analysis insights on Talphera Inc. performance2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
Using data tools to time your Talphera Inc. exitWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
Can Talphera Inc. rally from current levelsWeekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
D pipelineJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
Talphera Inc. stock chart pattern explained2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Will Talphera Inc. stock maintain dividend yieldEntry Point & AI Powered Buy/Sell Recommendations - newser.com
Can Talphera Inc. stock hit record highs againExit Point & Intraday High Probability Setup Alerts - newser.com
How buybacks impact Talphera Inc. stock valueGap Up & Reliable Entry Point Trade Alerts - newser.com
What MACD and RSI say about Talphera Inc.Inflation Watch & Fast Exit and Entry Strategy Plans - newser.com
What drives Talphera Inc R5XA stock priceStraddle and Strangle Trades & Explosive Profit Growth - earlytimes.in
Key resistance and support levels for Talphera Inc.2025 Price Momentum & Smart Investment Allocation Tips - newser.com
What valuation multiples suggest for Talphera Inc. stock2025 Trading Recap & Growth Oriented Trade Recommendations - newser.com
Can Talphera Inc. stock double in next 5 yearsWeekly Gains Summary & Weekly Return Optimization Plans - Fundação Cultural do Pará
Analyzing Talphera Inc. with multi timeframe charts2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Why Talphera Inc. stock remains a top recommendationJobs Report & Consistent Profit Trade Alerts - Fundação Cultural do Pará
How strong dollar benefits Talphera Inc. (R5XA) stockJuly 2025 Catalysts & Weekly High Momentum Picks - newser.com
Will Talphera Inc. stock outperform growth indexesTrade Entry Report & Smart Allocation Stock Reports - Fundação Cultural do Pará
How Talphera Inc. stock performs in high volatility marketsInsider Buying & Daily Technical Stock Forecast Reports - Fundação Cultural do Pará
Talphera’s Niyad Study: A Potential Game-Changer in Renal Therapy - TipRanks
Breakout Zone: What valuation multiples suggest for Talphera Inc. stock2025 Key Lessons & Proven Capital Preservation Tips - Fundação Cultural do Pará
Talphera Inc Stock (TLPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Talphera Inc Stock (TLPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | 
|---|---|---|---|---|---|---|---|
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | Dec 05 '24 | Buy | 0.64 | 5,000 | 3,200 | 208,066 | 
| ASADORIAN RAFFI | Chief Financial Officer | Dec 02 '24 | Sale | 0.77 | 155 | 119 | 37,578 | 
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | Nov 27 '24 | Buy | 0.73 | 5,000 | 3,650 | 203,066 | 
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App